Kim, Hansoo
Comey, Samantha
Hausler, Karl
Cook, Greg
Funding for this research was provided by:
Bristol-Myers Squibb Australia
Article History
Received: 14 June 2017
Accepted: 25 January 2018
First Online: 13 February 2018
Ethics approval and consent to participate
: This study was conducted as a condition of ipilimumab PBS listing. Registration of patients required patient consent in order to perform the 2 year follow up. Personal details such as name, date of birth and address were not captured and instead each patient was given a unique reference identification number.
: Not applicable.
: All authors are employed by Bristol-Myers Squibb Australia.